NasdaqGS - Nasdaq Real Time Price USD

Walgreens Boots Alliance, Inc. (WBA)

Compare
9.19 -0.06 (-0.59%)
As of 2:17 PM EDT. Market Open.
Loading Chart for WBA
DELL
  • Previous Close 9.25
  • Open 9.30
  • Bid 9.19 x 100
  • Ask 9.23 x 1300
  • Day's Range 9.16 - 9.48
  • 52 Week Range 9.03 - 27.05
  • Volume 10,147,747
  • Avg. Volume 19,984,125
  • Market Cap (intraday) 7.938B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) --
  • EPS (TTM) -6.74
  • Earnings Date Oct 10, 2024 - Oct 14, 2024
  • Forward Dividend & Yield 1.00 (10.81%)
  • Ex-Dividend Date Aug 21, 2024
  • 1y Target Est 12.36

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

www.walgreensbootsalliance.com

206,000

Full Time Employees

August 31

Fiscal Year Ends

Recent News: WBA

View More

Research Reports: WBA

View More

Performance Overview: WBA

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

WBA
63.03%
S&P 500
17.51%

1-Year Return

WBA
61.31%
S&P 500
24.62%

3-Year Return

WBA
77.45%
S&P 500
24.30%

5-Year Return

WBA
76.54%
S&P 500
91.66%

Compare To: WBA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WBA

View More

Valuation Measures

Annual
As of 8/29/2024
  • Market Cap

    7.99B

  • Enterprise Value

    39.96B

  • Trailing P/E

    --

  • Forward P/E

    4.32

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.05

  • Price/Book (mrq)

    0.59

  • Enterprise Value/Revenue

    0.27

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.99%

  • Return on Assets (ttm)

    1.30%

  • Return on Equity (ttm)

    -55.97%

  • Revenue (ttm)

    145.53B

  • Net Income Avi to Common (ttm)

    -5.81B

  • Diluted EPS (ttm)

    -6.74

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    711M

  • Total Debt/Equity (mrq)

    218.17%

  • Levered Free Cash Flow (ttm)

    2.17B

Research Analysis: WBA

View More

Company Insights: WBA

People Also Watch